Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neuphoria Therapeutics (NEUP) Other Operating Expenses (2025)

Historic Other Operating Expenses for Neuphoria Therapeutics (NEUP) over the last 1 years, with Q4 2025 value amounting to $1.2 million.

  • Neuphoria Therapeutics' Other Operating Expenses changed N/A to $1.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of -$1.1 million for FY2020, which is N/A changed from last year.
  • Neuphoria Therapeutics' Other Operating Expenses amounted to $1.2 million in Q4 2025.
  • Neuphoria Therapeutics' 5-year Other Operating Expenses high stood at $1.2 million for Q4 2025, and its period low was $1.2 million during Q4 2025.